{"SPADE_N_14089": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14089", "Peptide Name": "GF-19 (Synthetic AMPs, GF-17 analog, UCLL1)", "Source": "amino acid appending, Derivative of GF-17, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "GFKRIVQRIKDFLRNLVKL", "Sequence Length": 19, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Antiviral"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2343.86, "PI": 11.73, "Hydrophobicity": -0.09, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Thathapudi NC, Callai-Silva N, Malhotra K, Basu S, Aghajanzadeh-Kiyaseh M, Zamani-Roudbaraki M, Groleau M, Lombard-Vadnais F, Lesage S, Griffith M.2024", "Reference": "Sci Rep. 2024 Feb 19;14(1):4096. doi: 10.1038/s41598-024-53662-4.PubMed", "Title": "Modified host defence peptide GF19 slows TNT-mediated spread of corneal herpes simplex virus serotype I infection."}], "Frequent Amino Acids": "KLR", "Absent Amino Acids": "ACEHMOPSTUWY", "Basic Residues": 6, "Acidic Residues": 1, "Hydrophobic Residues": 9, "Polar Residues": 10, "Positive Residues": 6, "Negative Residues": 1, "Net Charge": 5, "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (89.47%) toGF-17GF-19 = GF-17 + KL.Activity: it inhibited herpes simplex virus serotype I (HSV-1).MOA:virus: probably block viral entry.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_12420", "Similarity": 1.0, "Sequence": "GFKRIVQRIKDFLRNLV"}, {"SPADE_ID": "SPADE_UN_12427", "Similarity": 1.0, "Sequence": "GFKRIVQRIKDFLRNL"}, {"SPADE_ID": "SPADE_UN_15093", "Similarity": 1.0, "Sequence": "GFKRIVQRIKDFLRNLV"}]}}}